SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 68 filers reported holding SOLENO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -16.7% | 105,481 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | -44.2% | 105,481 | 0.0% | 0.00% | – |
| Q4 2021 | $43,000 | -55.7% | 105,481 | 0.0% | 0.00% | – |
| Q3 2021 | $97,000 | -19.2% | 105,481 | 0.0% | 0.00% | – |
| Q2 2021 | $120,000 | -84.3% | 105,481 | -82.6% | 0.00% | – |
| Q1 2021 | $763,000 | -40.9% | 605,362 | -9.6% | 0.00% | – |
| Q4 2020 | $1,292,000 | -18.0% | 669,610 | +6.7% | 0.00% | – |
| Q3 2020 | $1,575,000 | +89.8% | 627,686 | +68.0% | 0.00% | – |
| Q2 2020 | $830,000 | +634.5% | 373,574 | +689.2% | 0.00% | – |
| Q1 2020 | $113,000 | +63.8% | 47,333 | +100.4% | 0.00% | – |
| Q4 2019 | $69,000 | +187.5% | 23,618 | +103.1% | 0.00% | – |
| Q1 2019 | $24,000 | +20.0% | 11,630 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -20.0% | 11,630 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | -7.4% | 11,630 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | – | 11,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $9,500,000 | 2.16% |
| Nantahala Capital Management | 9,765,129 | $9,028,000 | 0.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $1,971,000 | 0.24% |
| Granite Point Capital Management, L.P. | 701,838 | $649,000 | 0.05% |
| OPPENHEIMER & CO INC | 639,140 | $591,000 | 0.01% |
| Ikarian Capital, LLC | 121,694 | $112,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $28,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $9,000 | 0.01% |
| Ergoteles LLC | 74,525 | $69,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 744,000 | $688,000 | 0.00% |